GlaxoSmithKline Phar Dividend yield

 Price  1,318.75
 Dividend  29.94
 Earnings  100.67
 Cash-flow  50.33
 Book value  156.99
 Equity  122.92

GlaxoSmithKline Phar is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. GlaxoSmithKline Phar is a company from India, and his stocks are publicly traded.

GlaxoSmithKline Phar paid a total dividend of 5,060 million INR last year, for a market value of 222,869 millions (Market Cap 55,851 millions). Dividend per share of GlaxoSmithKline Phar is 29.94 INR, and his stock market price 1,318.75 INR.

According to the chart below, where dividend yield is displayed, GlaxoSmithKline Phar has a dividend yield of 2.27%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare GlaxoSmithKline Phar dividend yield with other Pharmaceuticals and Biotechnology companies or firms from India.

Dividend yield of GlaxoSmithKline Phar

GlaxoSmithKline Phar Dividend Payout

About the ability of GlaxoSmithKline Phar to maintain his current dividend of INR 29.94 per share, an amount that accounts for 2.27%, we should study its payout ratio both on earnings and on cash-flows (see chart below). GlaxoSmithKline Phar payout on ernings is currently 29.74%, which is lower than the market average and companies of Health Care industry, which are 41.22% and 34.13% respectively. Both figures lead us to believe that there is confidence that GlaxoSmithKline Pharcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of GlaxoSmithKline Phar is INR 50.33 per share, which is higher than the dividend per share paid by the company of INR 29.94, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of GlaxoSmithKline Phar, compared againt world market average, India companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

GlaxoSmithKline Phar payout

GlaxoSmithKline Phar Dividend History

Year Yield  INR  Paypout  Shares* 

*In millions

GlaxoSmithKline Phar Stock performance

Finally, last moth GlaxoSmithKline Phar showed a return of -1.40% compared to a worldwide -2.30% average, and a -1.20% of Health Care firms. Over the last year, the company obtained a -21.90% versus a worldwide performance of a -5.85%. More detailed information can be seen in the following graph for India and Pharmaceuticals and Biotechnology firms.

GlaxoSmithKline Phar stock and market return